Funding
Funding not disclosed
Founders
Product
Problem
Many patients suffer from chronic, non-healing wounds, particularly those with diabetes or peripheral artery disease (PAD), which can lead to significant morbidity, amputation, and high healthcare costs. Current treatments often fail to adequately address the underlying issues of poor blood flow and impaired tissue regeneration in these wounds.
Solution
VascuStim is developing a combination therapy that utilizes bioelectric stimulation and amniotic fluid to promote wound healing. The bioelectric stimulator delivers microcurrents to upregulate the expression of pro-regenerative proteins, such as SDF-1, VEGF, and IGF, which stimulate stem cell homing, angiogenesis, and cellular repair. Amniotic fluid, rich in growth factors and stem cells, is applied directly to the wound to further enhance tissue regeneration and reduce inflammation. This combined approach aims to restore blood flow, promote tissue regeneration, and accelerate the healing process in chronic, non-healing wounds.
Target Audience
The primary target audience includes vascular surgeons, wound care specialists, and physicians treating patients with chronic, non-healing wounds, diabetic foot ulcers, critical limb ischemia, and peripheral artery disease.
Features
- Bioelectric stimulation to upregulate key pro-regenerative proteins (SDF-1, VEGF, IGF, Klotho)
- Amniotic fluid membrane application to provide growth factors and stem cells
- Non-adhesive sterile gauze dressing to protect the wound
- Optional amniotic fluid injection around the wound site
- Prizm stocking for overnight added bioelectric stimulation
- Customizable bioelectric signals for controlled protein expression